Opportunity ID: 109474

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-11-269
Funding Opportunity Title: Pre-Application for the 2012 NIDA Translational Avant-Garde Award for Medication Development for the Treatment of Substance-Use Disorders (X02)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jul 29, 2011
Last Updated Date:
Original Closing Date for Applications: Oct 20, 2011
Current Closing Date for Applications: Oct 20, 2011
Archive Date: Nov 20, 2011
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Special district governments
Small businesses
Private institutions of higher education
City or township governments
Public housing authorities/Indian housing authorities
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
County governments
Independent school districts
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this funding opportunity announcement (FOA) is to encourage pre-applications for the NIDA Translational Avant-Garde Award. The NIDA Translational Avant-Garde Award is designed to support dedicated and talented basic and/or clinical researchers with the vision, drive and expertise necessary to translate research discoveries into medications for the treatment of Substance-Use Disorders (SUDs). Through this FOA, the National Institute on Drug Abuse (NIDA) is committed to making significant advances in the development of safe and efficacious medications for the treatment of SUDs stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use or abuse.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-11-269.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.279 ADOBE-FORMS-B1 ADOBE-FORMS-B1 PKG00067770 Sep 20, 2011 Oct 20, 2011 View

Package 1

Mandatory forms

109474 RR_SF424_1_2-1.2.pdf

109474 RR_KeyPersonExpanded_1_2-1.2.pdf

109474 PHS398_ResearchPlan_1_3-1.3.pdf

109474 PHS398_CoverPageSupplement_1_4-1.4.pdf

109474 RR_OtherProjectInfo_1_3-1.3.pdf

109474 PerformanceSite_1_4-1.4.pdf

Optional forms

109474 PHS_CoverLetter_1_2-1.2.pdf

2025-07-13T12:46:50-05:00

Share This Post, Choose Your Platform!

About the Author: